On the potential involvement of CD11d in co-stimulating the production of interferon- by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3
- 28 June 2011
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 96 (10), 1543-1547
- https://doi.org/10.3324/haematol.2011.044578
Abstract
Interaction between neutrophils and other leukocytes plays a variety of important roles in regulating innate and adaptive immune responses. Recently, we have shown that neu-trophils amplify NK cell/6-sulfo LacNAc(+) dendritic cells (slanDC)-mediated cytokine production, by potentiating IL-12p70 release by slanDC via CD18/ICAM-1 and directly co-stimulating IFNγ production by NK cells via ICAM-3. Herein, we have identified additional molecules involved in the interactions among neutrophils, NK cells and slanDC. More specifically, we provide evidence that: i) the cross-talk between neutrophils and NK cells is mediated by ICAM-3 and CD11d/CD18, respectively; ii) slanDC potentiate the production of IFNγ by NK cells via CD11a/CD18. Altogether, our studies shed more light on the role that adhesion molecules play within the neutrophil/NK cell/slanDC network. Our data also have potential implications in the pathogenesis of diseases driven by hyperactivated leukocytes, such as Sweet's syndrome, in which a neutrophil/NK cell co-localization is frequently observed.This publication has 21 references indexed in Scilit:
- Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFNγ: role of CD18, ICAM-1, and ICAM-3Blood, 2011
- Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytesBlood, 2002
- DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory AgentsThe Journal of Immunology, 2002
- Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune ResponsesCell, 2000
- A novel leukocyte adhesion deficiency caused by expressed but nonfunctional β2 integrins Mac-1 and LFA-1JCI Insight, 1999
- Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.The Journal of Immunology, 1996
- A novel leukointegrin, αdβ2, binds preferentially to ICAM-3Immunity, 1995
- Epitope mapping and functional properties of anti-intercellular adhesion molecule-3 (CD50) monoclonal antibodiesEuropean Journal of Immunology, 1995
- Cloning and characterization of a new intercellular adhesion molecule ICAM-RNature, 1992
- Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytesNature, 1992